Credit: Shutterstock Early results from a phase II clinical trial shows promise for curbing postpartum depression (PPD), a rare but extreme mood disorder which affects new mothers. The bio-pharmaceutical company, Sage Therapeutics announced the early findings of the intravenous drug SAGE-547 last week. According to a 2013 publication in […]
Make a Donation
BK Reader is brought to you for free daily. Please consider supporting independent local news by making a donation here. Whether it is $1 or $100, no donation is too big or too small!